TEVA PHARMACEUTICAL $40.23

up +0.27


17/5/2013 05:17 PM  |  NYSE : TEVA  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing
Quotes displayed are delayed by 15 minutes. Market data is provided by Telvent DTN
12 Mo. Price Change : 0% - TEVA has underperformed the S&P 500 by 25%

Get Trend Analysis Icon Get Trend Analysis

ETF Alternatives sponsored by



People viewing TEVA also viewed: , , , ,

Competitors

Ticker Name Volume % Change
ACEL TAMIR BIOTECHNOLOGY 12.3K +1.86%
BOMDF ALLIED HEALTHCARE GROUP 18.8K +1.27%
HRDND DC BRANDS INTERNATIONAL INC. N 2.6M +1.00%
TRAB THERABIOGEN 970.8K +1.00%
NRGXQ NEUROLOGIX 100.0K +0.82%

TEVA Stock Analysis

  1. Adasuve Deal Is Very Good For Alexza, But What About Teva?

    Teva's partnership with Alexza looks like an expensive gamble.
  2. Amgen Chased By The Bubble

    Amgen really needs the pipeline to come through to support this valuation.
  3. Teva Still Too Cheap, But Still Too Uncertain

    Teva's present-day momentum is weak, but the value could appeal to patient long-term investors.
  4. Natural Gas: A Big Win For Israel And Its Producers

    While it’s a tech powerhouse, the natural gas game is quickly changing Israel’s economy for the good. The recent prolific discoveries and new production will be a game changer for its economy. Investors should follow suite into the nation either through a broad Israel fund or Noble Energy.
Free Reports
  1. 3 Stocks Peter Lynch Would Buy Today

    This new special report identifies 3 stocks based on Lynch’s market-trouncing strategy that could more than double in the next 12 months.
  2. 4 Best Buy ETFs for the Current Market

    Don't miss this FREE Special Report from Forbes' fund and ETF expert Jim Lowell.
  3. 5 Chart Patterns Every Investor Needs To Know

    Learn How to Use Technical Analysis to Your Advantage.
Marketplace
Trading Center